Enlivex Therapeutics
ENLV
ENLV
4 hedge funds and large institutions have $220K invested in Enlivex Therapeutics in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.
Holders
4
Holders Change
+2
Holders Change %
+100%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Renaissance Technologies
New York
|
$178K |
| 2 |
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$37K |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$5K |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $178K | 78,060 | +28,900 | +59% |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $37K | 16,127 | +16,127 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $5K | 2,276 | +2,276 | New |
|
|
LTFS
4
Ladenburg Thalmann Financial Services
Miami,
Florida
| $0 | 200 | – | – |
|